高危骨髓增生异常综合征的治疗

李世俊; 齐军元

doi:10.3971/j.issn.1000-8578.2020.20.0412

李世俊, 齐军元. 高危骨髓增生异常综合征的治疗[J]. 肿瘤防治研究, 2020, 47(12): 996-1002. DOI: 10.3971/j.issn.1000-8578.2020.20.0412

引用本文:

李世俊, 齐军元. 高危骨髓增生异常综合征的治疗[J]. 肿瘤防治研究, 2020, 47(12): 996-1002. DOI: 10.3971/j.issn.1000-8578.2020.20.0412

LI Shijun, QI Junyuan. Treatment of High-risk Myelodysplastic Syndrome[J]. Cancer Research on Prevention and Treatment, 2020, 47(12): 996-1002. DOI: 10.3971/j.issn.1000-8578.2020.20.0412

Citation:

LI Shijun, QI Junyuan. Treatment of High-risk Myelodysplastic Syndrome[J]. Cancer Research on Prevention and Treatment, 2020, 47(12): 996-1002. DOI: 10.3971/j.issn.1000-8578.2020.20.0412

高危骨髓增生异常综合征的治疗

Treatment of High-risk Myelodysplastic Syndrome

摘要

摘要: 骨髓增生异常综合征（MDS）是一类造血干细胞恶性克隆性疾病，其治疗主要集中在表观遗传学治疗、化疗、干细胞移植以及新药方面，现将各种治疗方法进行综述。

Abstract: Myelodysplastic syndrome (MDS) is a kind of hematological malignancies, characterized by malignant clones in hematopoietic stem cells. The treatment mainly focused on epigenetic treatment, chemotherapy, stem cell transplantation and new drugs. This article summarized all these kinds of treatments.

HTML全文

参考文献(42)

施引文献

资源附件(0)

下载: 全尺寸图片幻灯片

返回文章

用微信扫码二维码

分享至好友和朋友圈